Results 81 to 90 of about 2,103,170 (215)

An Overview of Progress in the International Regulation of the Pharmaceutical Industry [PDF]

open access: yes, 2002
[Excerpt] “The pharmaceutical industry, a significant source of healthcare throughout the world, has several features that distinguish it from the rest of the health industry.
Burakoff, Aaron, Harvard University   +1 more
core   +1 more source

Travoprost Intracameral Implant in Eyes with Glaucoma or Ocular Hypertension: Early Short-Term Real-World Outcomes

open access: yesClinical Ophthalmology
Savak Teymoorian, Jasmin Kaur Harvard Eye Associates, Laguna Hills, CA, USACorrespondence: Savak Teymoorian, Harvard Eye Associates, 23961 Calle de la Magdalena, Suite 300, Laguna Hills, California, 92653, USA, Tel +1 949-951-2020, Fax +1 949-356-1660 ...
Teymoorian S, Kaur J
doaj  

A NEW VALIDATED METHOD FOR DETERMINATION OF ROFLUMILAST IN TABLET BY CZE-UV

open access: yesQuímica Nova
This paper reports a new and validated capillary electrophoresis method to determine Roflumilast (RFL) with an internal standard in tablet. The separation was made on an uncoated fused-silica capillary column 50 cm effective length and 75 µm i.d. 20 mmol
Tufan Güray
doaj   +1 more source

iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity

open access: yesFrontiers in Pharmacology
Many challenges remain in the preclinical evaluation, adjudication, and prioritization of novel compounds in therapeutic discovery pipelines. These obstacles are evident by the large number of candidate or lead compounds failing to reach clinical trials,
Tim Y. T. Lee   +7 more
doaj   +1 more source

Looking Ahead: Workforce Supply/Demand Analysis for New Jersey's Pharmaceutical and Medical Technology Industries [PDF]

open access: yes, 2005
This analysis presents the results of a workforce supply and demand analysis of the pharmaceutical and medical technology industries in New ...

core  

FDA New Drug Approval Times, Prescription Drug User Fees, and R & D Spending [PDF]

open access: yes
FDA-approval times have declined significantly since the enactment of the Prescription Drug User Fee Act (PDUFA) in 1992. As a result, present value expected returns to pharmaceutical R&D have likely increased.
Golec, Joseph H.   +3 more
core   +1 more source

Longitudinal Study on the Performance of U.S. Pharmaceutical Firms: The Increasing Role of Marketing [PDF]

open access: yes
Nowadays, the U.S. pharmaceutical industry has been under thorough scrutiny. Popular press claims of intensive marketing activities that go beyond R&D, the strong increase of me-too drugs, and, at the same time, the high industry profitability have ...
Pattikawa, L.H.
core   +1 more source

Role of Quality Management in Pharmaceutical Development: Evidence from Islamabad and Lahore [PDF]

open access: yes
The aim of this paper is to investigate the employee’s perceptions of the impact, of Total Quality Management (TQM), on their roles within the organization and how they perceived the effectiveness of the quality processes in Pakistan Pharmaceutical ...
M. Rashid Salaria   +2 more
core  

Indian Pharma Within Global Reach? [PDF]

open access: yes
The Indian pharmaceutical industry is presently going through a phase of transition and potential consolidation, owing to India's new TRIPS-compliant intellectual property regime and other rules aimed at enhancing the industry's credibility nationally ...
Gehl Sampath, Padmashree
core  

Pharmaceuticals entering Lake Champlain and their combination effects on developing Zebrafish Embryos [PDF]

open access: yes, 2017
Human-derived pharmaceuticals have been identified entering surface waters in the United States through wastewater effluent. While there is ample literature about what each compound alone does to aquatic life, little is known about the effects aquatic ...
Ferraro, Ariana R
core   +1 more source

Home - About - Disclaimer - Privacy